Company Filing History:
Years Active: 2018-2019
Title: Innovations of Samuel A Jensen
Introduction
Samuel A Jensen is a notable inventor based in Bloomington, MN (US). He has made significant contributions to the field of nanotechnology, particularly in the development of nanoconjugates that can effectively cross the blood-brain barrier. With a total of 2 patents, his work is paving the way for advancements in therapeutic applications for central nervous system disorders.
Latest Patents
Jensen's latest patents focus on nanoconjugates that address critical challenges in therapeutic use. One of his key inventions is a single-entity, targeted therapeutic that can cross the blood-brain barrier (BBB). This innovation is particularly effective in treating central nervous system (CNS) disorders. Notably, despite the high cellular uptake of these nanoconjugates, they exhibit no toxicity in the tested cell types. This property is essential for therapeutic agent delivery applications, as it helps reduce off-target effects. Another patent also emphasizes the methods of therapeutic use for nanoconjugates that cross the blood-brain barrier.
Career Highlights
Samuel A Jensen is affiliated with Northwestern University, where he continues to advance his research in nanotechnology. His work has garnered attention for its potential impact on medical treatments and drug delivery systems.
Collaborations
Jensen has collaborated with esteemed colleagues such as Chad A Mirkin and Caroline H Ko. These partnerships have further enriched his research and contributed to the development of innovative solutions in the field.
Conclusion
Samuel A Jensen's contributions to nanotechnology and his innovative patents highlight his role as a leading inventor in the field. His work not only addresses significant medical challenges but also opens new avenues for therapeutic applications.